Kamon Phuakpet

Bangkok, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Granulocyte transfusion improves survival in pediatric febrile neutropenia: a 15-year cohort study.

Granulocyte transfusion improves survival in pediatric febrile neutropenia: a 15-year cohort study.

Journal: Clinical and experimental pediatrics

Published: May 30, 2025

Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents.

Characteristics and therapeutic outcomes of subcutaneous panniculitis-like T-cell lymphoma with and without germline HAVCR2 mutations in Thai children and adolescents.

Journal: Orphanet journal of rare diseases

Published: May 04, 2024

Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.

Germline HAVCR2 mutations and their relation to the clinical spectrum of subcutaneous panniculitis-like T-cell lymphoma and hemophagocytic lymphohistiocytosis: results from a multicenter study and meta-analysis.

Journal: Haematologica

Published: November 14, 2022

Outcomes of Overt and Non-overt Disseminated Intravascular Coagulation Using the ISTH DIC Scoring System in Children: A Single-Center Study.

Outcomes of Overt and Non-overt Disseminated Intravascular Coagulation Using the ISTH DIC Scoring System in Children: A Single-Center Study.

Journal: Mediterranean journal of hematology and infectious diseases

Published: August 09, 2022

Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.

Ototoxicity and long-term hearing outcome in pediatric patients receiving cisplatin.

Journal: The Turkish journal of pediatrics

Published: July 28, 2022

Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.

Treatment outcomes among high-risk neuroblastoma patients receiving non-immunotherapy regimen: Multicenter study on behalf of the Thai Pediatric Oncology Group.

Journal: Pediatric blood & cancer

Published: December 28, 2021

Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing.

Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing.

Journal: Mediterranean journal of hematology and infectious diseases

Published: August 01, 2021

Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience.

Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience.

Journal: Journal of blood medicine

Published: May 20, 2021

Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia.

Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia.

Journal: Mediterranean journal of hematology and infectious diseases

Published: January 31, 2021

Using of deferasirox and deferoxamine in refractory iron overload thalassemia.

Using of deferasirox and deferoxamine in refractory iron overload thalassemia.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: May 14, 2020

Clinical outcomes and prognosis of Thai retinoblastoma patients.

Clinical outcomes and prognosis of Thai retinoblastoma patients.

Journal: Pediatrics international : official journal of the Japan Pediatric Society

Published: March 25, 2020

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.

Clinical outcomes and prognostic factors to predict treatment response in high risk neuroblastoma patients receiving topotecan and cyclophosphamide containing induction regimen: a prospective multicenter study.

Journal: BMC cancer

Published: June 05, 2019

Showing 1-12 of 17

Last Updated: 09/26/2026